Kojin Therapeutics Patents – Insights & Stats (Updated 2023)

Kojin Therapeutics has a total of 4 patents globally, out of which 1 have been granted. Of these 4 patents, all the patents are active. The United States of America is where Kojin Therapeutics has filed all the patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kojin Therapeutics.

Kojin Therapeutics was founded in 2020. Kojin is creating best-in-class therapies for patients with cancer, cardiovascular, immunologic, and degenerative disorders by utilizing novel insights in cell-state and ferroptosis biology. In order to find treatments that precisely alter ferroptosis, Kojin has created a drug-discovery platform that combines structural biology, chemical biology, target-informed screening, and mechanism-driven pharmacology.

Do read about some of the most popular patents of Kojin Therapeutics which have been covered by us in this article and also you can find Kojin Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kojin Therapeutics patent portfolio.

How many patents does Kojin Therapeutics have?

Kojin Therapeutics has a total of 4 patents globally. These patents belong to 3 unique patent families. Out of 4 patents, all the patents are active.

How Many Patents did Kojin Therapeutics File Every Year?

Kojin Therapeutics filled 4 patent parallelly the filling years are 2022 and 2023.

Year of Patents Filing or GrantKojin Therapeutics Applications FiledKojin Therapeutics Patents Granted
202311
20223

How many Kojin Therapeutics patents are Alive/Dead?

All the patents of Kojin Therapeutics are alive.

How Many Patents did Kojin Therapeutics File in Different Countries?

Kojin Therapeutics has filed all the patents in the United States of America.

Where are Research Centers of Kojin Therapeutics Patents Located?

The Research Center of Kojin Therapeutics is the United States of America.

What Percentage of Kojin Therapeutics US Patent Applications Were Granted?

Kojin Therapeutics (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Kojin Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Kojin Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Greenberg Traurig Llp1100%

List of Kojin Therapeutics patents

Kojin Therapeutics PatentsTitle
US11541116B1Methods And Compositions For Inducing Ferroptosis In Vivo
US20230226185A1Methods And Compositions For Inducing Ferroptosis In Vivo
WO2023240204A2Methods And Compositions For Initiating, Regulating, And Modulating Weight Loss And Therapeutic Applications Thereof
WO2023133053A3Methods And Compositions For Inducing Ferroptosis In Vivo

What are Kojin Therapeutics key innovation segments?

What Technologies are Covered by Kojin Therapeutics?

The chart below distributes patents filed by Kojin Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Kojin Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kojin Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kojin Therapeutics?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.